Shots:

• Yas Holding entered into an exclusive license and distribution agreement with Alvogen to commercialize its targeted generic pharmaceuticals portfolio in MENA region
• The collaboration will expand Alvogen’s presence in the MENA region including Gulf- KSA- Levant- North Africa and Sub-Saharan Africa and will improve clinical outcomes and QoL of patients in the MENA region
• Alvogen’s generic portfolio comprises of 28 products for oncology- autoimmune- inflammation and blood diseases and will be commercialized from 2020

Click here to­ read full press release/ article | Ref: Alvogen | Image: Alvogen